Observational study explores pregabalin dependence in substance use disorder patients, suggesting urgent screening strategies.
These high estimates for non-medical use and dependence of pregabalin in our study are an early indication of rising problem of pregabalin use amongst the patients with substance use disorders. We draw attention of the healthcare providers and policy makers in formulation of strategies to screen for pregabalin non-medical use and dependence, formulate treatment strategies and devise policy changes to address diversion of pregabalin in view of its non-medical use potential.
No takes yet. Share an insight, caveat, or question.
Aneja et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: